Literature DB >> 22748592

Cholera.

Jason B Harris1, Regina C LaRocque2, Firdausi Qadri3, Edward T Ryan4, Stephen B Calderwood5.   

Abstract

Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120,000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0·2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748592      PMCID: PMC3761070          DOI: 10.1016/S0140-6736(12)60436-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  144 in total

1.  Cholera vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-26

2.  Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe.

Authors:  M Sirajul Islam; Stanley M Midzi; Lincoln Charimari; Alejandro Cravioto; Hubert P Endtz
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

3.  Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

Authors:  M M Levine; J B Kaper; D Herrington; J Ketley; G Losonsky; C O Tacket; B Tall; S Cryz
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

Review 4.  Survival strategies of bacteria in the natural environment.

Authors:  D B Roszak; R R Colwell
Journal:  Microbiol Rev       Date:  1987-09

5.  Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.

Authors:  R I Glass; J Holmgren; C E Haley; M R Khan; A M Svennerholm; B J Stoll; K M Belayet Hossain; R E Black; M Yunus; D Barua
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

6.  Transferable quinolone resistance in Vibrio cholerae.

Authors:  Hong Bin Kim; Minghua Wang; Sabeena Ahmed; Chi Hye Park; Regina C LaRocque; Abu S G Faruque; Mohammed A Salam; Wasif A Khan; Firdausi Qadri; Stephen B Calderwood; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

7.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera.

Authors:  J D Clemens; D A Sack; J R Harris; J Chakraborty; M R Khan; B F Stanton; M Ali; F Ahmed; M Yunus; B A Kay
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

9.  Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V. cholerae in children.

Authors:  A M Molla; M Rahman; S A Sarker; D A Sack; A Molla
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

10.  An evaluation of alkaline peptone water for enrichment of Vibrio cholerae in feces.

Authors:  M Lesmana; R C Rockhill; D Sutanti; A Sutomo
Journal:  Southeast Asian J Trop Med Public Health       Date:  1985-06       Impact factor: 0.267

View more
  222 in total

1.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Vibrio cholerae.

Authors:  Jenna Rychert; David Creely; Leslie M Mayo-Smith; Stephen B Calderwood; Louise C Ivers; Edward T Ryan; Jacques Boncy; Firdausi Qadri; Dilruba Ahmed; Mary Jane Ferraro; Jason B Harris
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

3.  Impact of Ramadan on clinical and microbiologic parameters of patients seen at a diarrheal hospital in urban Dhaka, Bangladesh, 1996-2012.

Authors:  Daniel T Leung; Sumon K Das; M A Malek; Firdausi Qadri; A S G Faruque; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

4.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

5.  Vibrio cholerae Virulence Activator ToxR Regulates Manganese Transport and Resistance to Reactive Oxygen Species.

Authors:  Hang-Hang Jiang; Yitian Zhou; Ming Liu; Jessie Larios-Valencia; Zachariah Lee; Hui Wang; Xing-Hua Gao; Jun Zhu
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

6.  Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.

Authors:  F Matthew Kuhlmann; Srikanth Santhanam; Pardeep Kumar; Qingwei Luo; Matthew A Ciorba; James M Fleckenstein
Journal:  Am J Trop Med Hyg       Date:  2016-05-09       Impact factor: 2.345

7.  Mechanisms of inflammasome activation by Vibrio cholerae secreted toxins vary with strain biotype.

Authors:  Jessica Queen; Shivani Agarwal; Jazel S Dolores; Christian Stehlik; Karla J F Satchell
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

8.  Cholera in travelers: shifting tides in epidemiology, management, and prevention.

Authors:  Katie Fillion; Maria D Mileno
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

9.  Tracking Vibrio cholerae Cell-Cell Interactions during Infection Reveals Bacterial Population Dynamics within Intestinal Microenvironments.

Authors:  Yang Fu; Brian T Ho; John J Mekalanos
Journal:  Cell Host Microbe       Date:  2018-02-02       Impact factor: 21.023

10.  Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring.

Authors:  Dazhi Jin; Yun Luo; Min Zheng; Haijing Li; Jing Zhang; Melinda Stampfl; Xiao Xu; Gangqiang Ding; Yanjun Zhang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.